Filter posts

Prosensa's IPO and the Value of the BIO Investor Forum

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of …

JOBS Act Provides Innovators with Capital Boost

Despite all the talk of gridlock and polarization in Washington these days, successful, bipartisan pieces …

BIO Investor Forum Company Snapshot: NovelMed Therapeutics

NovelMed Therapeutics will be presenting at the upcoming BIO Investor Forum in October in San …

GAINing Ground in Antibiotics

With the rise of antibiotic resistant “superbugs” in recent years, everyone agrees there is an …

BIO Investor Forum Company Snapshot: MAX BioPharma

Earlier this week, we featured a presenting company for our upcoming BIO Investor Forum event …

BIO Investor Forum Company Snapshot: AM-Pharma

The BIO Investor Forum will be taking place this October in San Francisco for its …

The Return of the Biotech IPO

It isn’t just the volume of IPOs this summer that makes this window a victory …

BIO Investor Forum Veterans Moving Up with the Recent Biotech Deal Surge

As detailed in The New York Times, the potential for deal-making in the industry has …

BIO Convention Post-Con, Plus a Look Ahead

Last month, the biopharma community gathered for the industry’s largest event, the BIO International Convention. …

It Takes a Village: The New Pharma-VC Model for Biotech Investing

High-profile funding collaborations between pharmaceutical companies and traditional venture capital funds have made headlines in …